Slow Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.41M Buy
4,509
+303
+7% +$310K 0.63% 53
2026
Q1
$3.87M Buy
4,206
+440
+12% +$446K 0.5% 65
2025
Q4
$4.05M Buy
3,766
+231
+7% +$221K 0.48% 61
2025
Q3
$2.7M Buy
3,535
+57
+2% +$42.4K 0.32% 85
2025
Q2
$2.71M Buy
+3,478
New +$2.7M 0.33% 82
2018
Q1
Sell
-31,617
Closed -$2.67M 210
2017
Q4
$2.67M Buy
+31,617
New +$2.69M 1.38% 15

Other funds holding LLY

Slow Capital's LLY Position: Q2 2026 in Review

Slow Capital increased its Eli Lilly (LLY) stake by 7.2% in Q2 2026, buying an estimated $310K and bringing the position to 4,509 shares worth $5.41M. The position accounts for 0.63% of the portfolio, ranked #53.

Slow Capital first reported a position in LLY in Q4 2017 and has held it in 6 quarters since. 1,692 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Slow Capital held 4,509 shares of Eli Lilly worth $5.41M as of Q2 2026.
  • Slow Capital bought 303 Eli Lilly shares in Q2 2026, an estimated $310K.
  • Eli Lilly made up 0.63% of Slow Capital's portfolio in Q2 2026, its #53 holding.
  • Slow Capital first reported a position in Eli Lilly in Q4 2017 and has held it in 6 quarters since.
  • 1,692 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Slow Capital's 13F filing for Q2 2026, filed 22 Jul 2026.